Benfotiamine milgamma ® mono 150.
Active ingredient: Benfotiamine 150 mg.
Areas of application: Therapy or prophylaxis of clinical vitamin B1 deficiencies, if these cannot be remedied nutritionally; Treatment of neuropathies and cardiovascular Sturgeon, d. caused by vitamin B1 deficiency.
For Benfotiamine information on risks and side effects, read the package insert and ask your doctor or pharmacist.
Wörwag Pharma GmbH & Co. KG, 71034 Boeblingen
Benfotiamine milgamma ® mono 150
For vitamin B1 deficiency
milgamma ®mono 150 contains vitamin B1 for the nerve cells. The unique active ingredient benfotiamine, a variant of vitamin B1, is absorbed by the body 5 times better than conventional vitamin B1. For the treatment and prophylaxis of vitamin B1 deficiencies.
milgamma ® mono 150 - For vitamin B1 deficiency:
• To compensate or prevent a vitamin B1 deficiency
• 150 mg BENFOTIAMIN, vitamin B1 precursor, which can be absorbed particularly well by the body
• BETTER ABSORPTION Benfotiamine is 5 times better than Body absorbed than conventional vitamin B1 preparations
• Well tolerated
• Lactose and gluten free